Literature DB >> 26072321

The Polymerase Chain Reaction: Essential for the Development of Curative Therapy for Hepatitis C.

Eoin R Feeney1, Raymond T Chung.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26072321      PMCID： PMC4499479          DOI： 10.1007/s10620-015-3748-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  36 in total

1.  Unbiased probing of the entire hepatitis C virus life cycle identifies clinical compounds that target multiple aspects of the infection.

Authors:  Pablo Gastaminza; Christina Whitten-Bauer; Francis V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-07       Impact factor: 11.205

2.  A cell protection screen reveals potent inhibitors of multiple stages of the hepatitis C virus life cycle.

Authors:  Karuppiah Chockalingam; Rudo L Simeon; Charles M Rice; Zhilei Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-08       Impact factor: 11.205

3.  The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection.

Authors:  Jason Grebely; Kimberly Page; Rachel Sacks-Davis; Maarten Schim van der Loeff; Thomas M Rice; Julie Bruneau; Meghan D Morris; Behzad Hajarizadeh; Janaki Amin; Andrea L Cox; Arthur Y Kim; Barbara H McGovern; Janke Schinkel; Jacob George; Naglaa H Shoukry; Georg M Lauer; Lisa Maher; Andrew R Lloyd; Margaret Hellard; Gregory J Dore; Maria Prins
Journal:  Hepatology       Date:  2013-11-22       Impact factor: 17.425

4.  Evaluation of liver disease progression in the German hepatitis C virus (1b)-contaminated anti-D cohort at 35 years after infection.

Authors:  Manfred Wiese; Janett Fischer; Micha Löbermann; Uwe Göbel; Kurt Grüngreiff; Wolfgang Güthoff; Ulrike Kullig; Franziska Richter; Ingolf Schiefke; Hannelore Tenckhoff; Alexander Zipprich; Thomas Berg; Tobias Müller
Journal:  Hepatology       Date:  2013-11-18       Impact factor: 17.425

5.  A sustained viral response is associated with reduced liver-related morbidity and mortality in patients with hepatitis C virus.

Authors:  Amit G Singal; Michael L Volk; Donald Jensen; Adrian M Di Bisceglie; Philip S Schoenfeld
Journal:  Clin Gastroenterol Hepatol       Date:  2009-11-27       Impact factor: 11.382

6.  Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection.

Authors:  Nezam Afdhal; Stefan Zeuzem; Paul Kwo; Mario Chojkier; Norman Gitlin; Massimo Puoti; Manuel Romero-Gomez; Jean-Pierre Zarski; Kosh Agarwal; Peter Buggisch; Graham R Foster; Norbert Bräu; Maria Buti; Ira M Jacobson; G Mani Subramanian; Xiao Ding; Hongmei Mo; Jenny C Yang; Phillip S Pang; William T Symonds; John G McHutchison; Andrew J Muir; Alessandra Mangia; Patrick Marcellin
Journal:  N Engl J Med       Date:  2014-04-11       Impact factor: 91.245

7.  Treatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin.

Authors:  Jordan J Feld; Kris V Kowdley; Eoin Coakley; Samuel Sigal; David R Nelson; Darrell Crawford; Ola Weiland; Humberto Aguilar; Junyuan Xiong; Tami Pilot-Matias; Barbara DaSilva-Tillmann; Lois Larsen; Thomas Podsadecki; Barry Bernstein
Journal:  N Engl J Med       Date:  2014-04-10       Impact factor: 91.245

8.  Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance.

Authors:  Dongliang Ge; Jacques Fellay; Alexander J Thompson; Jason S Simon; Kevin V Shianna; Thomas J Urban; Erin L Heinzen; Ping Qiu; Arthur H Bertelsen; Andrew J Muir; Mark Sulkowski; John G McHutchison; David B Goldstein
Journal:  Nature       Date:  2009-08-16       Impact factor: 49.962

Review 9.  Review article: HCV genotype 3 – the new treatment challenge.

Authors:  J Ampuero; M Romero-Gómez; K R Reddy
Journal:  Aliment Pharmacol Ther       Date:  2014-04       Impact factor: 8.171

10.  Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection.

Authors:  Mark S Sulkowski; David F Gardiner; Maribel Rodriguez-Torres; K Rajender Reddy; Tarek Hassanein; Ira Jacobson; Eric Lawitz; Anna S Lok; Federico Hinestrosa; Paul J Thuluvath; Howard Schwartz; David R Nelson; Gregory T Everson; Timothy Eley; Megan Wind-Rotolo; Shu-Pang Huang; Min Gao; Dennis Hernandez; Fiona McPhee; Diane Sherman; Robert Hindes; William Symonds; Claudio Pasquinelli; Dennis M Grasela
Journal:  N Engl J Med       Date:  2014-01-16       Impact factor: 91.245
View more
  1 in total

Review 1.  Putting Crohn's on the MAP: Five Common Questions on the Contribution of Mycobacterium avium subspecies paratuberculosis to the Pathophysiology of Crohn's Disease.

Authors:  Gaurav Agrawal; John Aitken; Harrison Hamblin; Michael Collins; Thomas J Borody
Journal:  Dig Dis Sci       Date:  2020-10-22       Impact factor: 3.199
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.